Skip to main content

and
  1. Article

    Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide–streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas

    A progressive loss of beta cell function and mass are important contributory factors in the development and progression of type 2 diabetes. The aim of this study was to evaluate the effects of a primary reduct...

    M. O. Larsen, B. Rolin, C. F. Gotfredsen, R. D. Carr, J. J. Holst in Diabetologia (2004)

  2. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)

  3. Article

    Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs

    M. O. Larsen PhD, C. F. Gotfredsen, M. Wilken, R. D. Carr, N. Pørksen in Diabetologia (2004)

  4. Article

    Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs

    Type 2 diabetes is associated with impaired insulin action and secretion, including disturbed pulsatile release. Impaired pulsatility has been related to impaired insulin action, thus providing a possible link...

    M. O. Larsen PhD, C. F. Gotfredsen, M. Wilken, R. D. Carr, N. Pørksen in Diabetologia (2003)

  5. Article

    The conscious Göttingen minipig as a model for studying rapid pulsatile insulin secretion in vivo

    Abstract

    M. Larsen, M. Elander, J. Sturis, M. Wilken, R. Carr, B. Rolin, N. Pørksen in Diabetologia (2002)

  6. Article

    Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats

    The role of glucagon in diabetic hyperglycaemia has been a matter of controversy because of difficulties in the production of selective glucagon deficiency. We developed a high-capacity (40 nmol/ ml), high-aff...

    C. L. Brand, B. Rolin, P. N. JØrgensen, I. Svendsen, J. S. Kristensen in Diabetologia (1994)